+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antibody Production Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables, Software), Type (Polyclonal Antibody, Monoclonal Antibody), Process, End Use, and Region with Growth Forecasts, 2025-2033- Product Image
Antibody Production Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables, Software), Type (Polyclonal Antibody, Monoclonal Antibody), Process, End Use, and Region with Growth Forecasts, 2025-2033- Product Image
New

Antibody Production Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables, Software), Type (Polyclonal Antibody, Monoclonal Antibody), Process, End Use, and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 180 Pages
  • September 2025
  • Region: Global
  • Grand View Research
  • ID: 5830938
REQUEST CUSTOMIZATION
Description Jump to:
The global antibody production market size was estimated at USD 17.03 Billion in 2025 and is projected to reach USD 39.80 billion by 2033, growing at a CAGR of 11.2% from 2025 to 2033. Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, coupled with the growing demand for therapeutic antibodies, has led to the rapid growth of the antibody production market.

Personalized and Next-Generation Antibodies

The global antibody production market is experiencing a significant shift as the industry moves beyond conventional monoclonal antibodies toward more complex, next-generation formats. Personalized therapies are increasingly becoming the standard of care, with bispecific antibodies, antibody-drug conjugates (ADCs), and engineered monoclonal antibodies emerging as critical tools in targeting diseases with greater precision and efficacy. These novel modalities not only enhance therapeutic outcomes but also open new opportunities for biopharmaceutical companies to differentiate their portfolios in an increasingly competitive landscape.

The rise of next-generation antibodies is fueling demand for advanced and highly specialized production technologies. Unlike traditional mAbs, which rely on relatively standardized production processes, bispecifics and ADCs require more sophisticated cell line development, purification techniques, and conjugation platforms. Manufacturers are rapidly adopting innovative solutions such as high-density perfusion bioreactors, modular single-use systems, and integrated continuous bioprocessing to meet these evolving requirements. This technological advancement is essential to achieve cost-effective scalability while maintaining the high quality and safety standards expected for complex biologics.

Market growth is further reinforced by strong investment flows from both established pharmaceutical players and emerging biotech firms aiming to capitalize on next-generation antibody pipelines. Partnerships, acquisitions, and capacity expansion initiatives are accelerating globally, with a particular focus on regions that are investing heavily in biopharma infrastructure. As regulatory frameworks evolve to accommodate these innovative therapies, companies that can align their production capabilities with the unique demands of personalized and next-generation antibodies are well positioned to capture a larger share of this expanding market. Ultimately, the convergence of scientific innovation, manufacturing excellence, and strategic investment is reshaping the antibody production landscape and sustaining robust long-term growth.

Global Antibody Production Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global antibody production market based on product, process, type, end use, and region.

Product Outlook (Revenue, USD Million, 2021-2033)

  • Instruments
  • Consumables

Process Outlook (Revenue, USD Million, 2021-2033)

  • Upstream Processing
  • Downstream Processing

Type Outlook (Revenue, USD Million, 2021-2033)

  • Monoclonal Antibody
  • Polyclonal Antibody

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical and biotechnology companies
  • Research laboratories
  • CROs and CDMOs

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Antibody Production Market Variables and Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Impact Analysis
3.2.1.1. Increased demand for therapeutic antibodies
3.2.1.2. Increasing investment in R&D
3.2.1.3. Rise in adoption of antibody production for personalized medicine and companion diagnostics
3.2.2. Market Restraint Impact Analysis
3.2.2.1. Stringent government regulations
3.3. Industry Analysis Tools
3.3.1. PESTEL Analysis
3.3.2. Porter’s Five Forces Analysis
Chapter 4. Antibody Production Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Antibody Production Market Product Movement Analysis
4.3. Global Antibody Production Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Instruments
4.4.1. Global Instruments Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Bioreactors
4.4.2.1. Global Bioreactors Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.4.2.2. Multi-use Bioreactor
4.4.2.2.1. Global Multi-Use Bioreactors Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.4.2.3. Single-use Bioreactor
4.4.2.3.1. Global Single-Use Bioreactors Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.4.3. Chromatography Systems
4.4.3.1. Global Chromatography Systems Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.4.4. Filtration Systems
4.4.4.1. Global Filtration Systems Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.5. Consumables
4.5.1. Global Consumables Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. Media
4.5.2.1. Global Media Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.5.3. Buffers and Reagents
4.5.3.1. Global Buffers and Reagents Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.5.4. Chromatography Resins and Columns
4.5.4.1. Global Chromatography Resins and Columns Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.5.5. Filtration Consumables and Accessories
4.5.5.1. Global Filtration Consumables and Accessories Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.5.6. Others
4.5.6.1. Global Others Market Estimates and Forecasts, 2021-2033 (USD Millions)
4.6. Software
4.6.1. Global Software Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Antibody Production Market: Process Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Antibody Production Market Process Movement Analysis
5.3. Global Antibody Production Market Size & Trend Analysis, by Process, 2021 to 2033 (USD Million)
5.4. Upstream Processing
5.4.1. Global Upstream Processing Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Downstream Processing
5.5.1. Global Downstream Processing Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Antibody Production Market: Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Antibody Production Market Type Movement Analysis
6.3. Global Antibody Production Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
6.4. Monoclonal Antibody
6.4.1. Global Monoclonal Antibody Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Polyclonal Antibody
6.5.1. Global Polyclonal Antibody Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Antibody Production Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Antibody Production Market End Use Movement Analysis
7.3. Global Antibody Production Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Pharmaceutical and Biotechnology Companies
7.4.1. Global Pharmaceutical and Biotechnology Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Research Laboratories
7.5.1. Global Research Laboratories Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. CROs and CDMOs
7.6.1. Global CROs and CDMOs Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Antibody Production Market: Regional Estimates & Trend Analysis
8.1. Antibody Production Market: Region Outlook
8.2. North America
8.2.1. North America Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Scenario
8.2.2.4. U.S. Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Scenario
8.2.3.4. Canada Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Scenario
8.2.4.4. Mexico Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3. Europe
8.3.1. Europe Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Scenario
8.3.2.4. UK Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Scenario
8.3.3.4. Germany Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Scenario
8.3.4.4. France Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Scenario
8.3.5.4. Italy Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Scenario
8.3.6.4. Spain Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Scenario
8.3.7.4. Denmark Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Scenario
8.3.8.4. Sweden Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Scenario
8.3.9.4. Norway Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4. Asia-Pacific
8.4.1. Asia-Pacific Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.2. China
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Scenario
8.4.2.4. China Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Scenario
8.4.3.4. Japan Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Scenario
8.4.4.4. India Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Scenario
8.4.5.4. South Korea Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Scenario
8.4.6.4. Australia Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Scenario
8.4.7.4. Thailand Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Latin America
8.5.1. Latin America Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Scenario
8.5.2.4. Brazil Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Scenario
8.5.3.4. Argentina Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6. MEA
8.6.1. MEA Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Scenario
8.6.2.4. South Africa Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Scenario
8.6.3.4. Saudi Arabia Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Scenario
8.6.4.4. UAE Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Scenario
8.6.5.4. Kuwait Antibody Production Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Lonza Group
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Thermo Fisher Scientific, Inc.
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. AGC Biologics
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Wuxi Biologics
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Charles River Laboratories
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Biointron
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Danaher
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Sartorius
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Eppendorf
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Merck KGaA
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 Global antibody production market, by product, 2021-2033 (USD Million)
Table 3 Global antibody production market, by process, 2021-2033 (USD Million)
Table 4 Global antibody production market, by type, 2021-2033 (USD Million)
Table 5 Global antibody production market, by end use, 2021-2033 (USD Million)
Table 6 Global antibody production market, by region, 2021-2033 (USD Million)
Table 7 North America antibody production market, by country, 2021-2033 (USD Million)
Table 8 North America antibody production market, by product, 2021-2033 (USD Million)
Table 9 North America antibody production market, by process, 2021-2033 (USD Million)
Table 10 North America antibody production market, by type, 2021-2033 (USD Million)
Table 11 North America antibody production market, by end use, 2021-2033 (USD Million)
Table 12 U.S. antibody production market, by product, 2021-2033 (USD Million)
Table 13 U.S. antibody production market, by process, 2021-2033 (USD Million)
Table 14 U.S. antibody production market, by type, 2021-2033 (USD Million)
Table 15 U.S. antibody production market, by end use, 2021-2033 (USD Million)
Table 16 Canada antibody production market, by product, 2021-2033 (USD Million)
Table 17 Canada antibody production market, by process, 2021-2033 (USD Million)
Table 18 Canada antibody production market, by type, 2021-2033 (USD Million)
Table 19 Canada antibody production market, by end use, 2021-2033 (USD Million)
Table 20 Mexico antibody production market, by product, 2021-2033 (USD Million)
Table 21 Mexico antibody production market, by process, 2021-2033 (USD Million)
Table 22 Mexico antibody production market, by type, 2021-2033 (USD Million)
Table 23 Mexico antibody production market, by end use, 2021-2033 (USD Million)
Table 24 Europe antibody production market, by country, 2021-2033 (USD Million)
Table 25 Europe antibody production market, by product, 2021-2033 (USD Million)
Table 26 Europe antibody production market, by process, 2021-2033 (USD Million)
Table 27 Europe antibody production market, by type, 2021-2033 (USD Million)
Table 28 Europe antibody production market, by end use, 2021-2033 (USD Million)
Table 29 Germany antibody production market, by product, 2021-2033 (USD Million)
Table 30 Germany antibody production market, by process, 2021-2033 (USD Million)
Table 31 Germany antibody production market, by type, 2021-2033 (USD Million)
Table 32 Germany antibody production market, by end use, 2021-2033 (USD Million)
Table 33 UK antibody production market, by product, 2021-2033 (USD Million)
Table 34 UK antibody production market, by process, 2021-2033 (USD Million)
Table 35 UK antibody production market, by type, 2021-2033 (USD Million)
Table 36 UK antibody production market, by end use, 2021-2033 (USD Million)
Table 37 France antibody production market, by product, 2021-2033 (USD Million)
Table 38 France antibody production market, by process, 2021-2033 (USD Million)
Table 39 France antibody production market, by type, 2021-2033 (USD Million)
Table 40 France antibody production market, by end use, 2021-2033 (USD Million)
Table 41 Italy antibody production market, by product, 2021-2033 (USD Million)
Table 42 Italy antibody production market, by process, 2021-2033 (USD Million)
Table 43 Italy antibody production market, by type, 2021-2033 (USD Million)
Table 44 Italy antibody production market, by end use, 2021-2033 (USD Million)
Table 45 Spain antibody production market, by product, 2021-2033 (USD Million)
Table 46 Spain antibody production market, by process, 2021-2033 (USD Million)
Table 47 Spain antibody production market, by type, 2021-2033 (USD Million)
Table 48 Spain antibody production market, by end use, 2021-2033 (USD Million)
Table 49 Denmark antibody production market, by product, 2021-2033 (USD Million)
Table 50 Denmark antibody production market, by process, 2021-2033 (USD Million)
Table 51 Denmark antibody production market, by type, 2021-2033 (USD Million)
Table 52 Denmark antibody production market, by end use, 2021-2033 (USD Million)
Table 53 Sweden antibody production market, by product, 2021-2033 (USD Million)
Table 54 Sweden antibody production market, by process, 2021-2033 (USD Million)
Table 55 Sweden antibody production market, by type, 2021-2033 (USD Million)
Table 56 Sweden antibody production market, by end use, 2021-2033 (USD Million)
Table 57 Norway antibody production market, by product, 2021-2033 (USD Million)
Table 58 Norway antibody production market, by process, 2021-2033 (USD Million)
Table 59 Norway antibody production market, by type, 2021-2033 (USD Million)
Table 60 Norway antibody production market, by end use, 2021-2033 (USD Million)
Table 61 Asia-Pacific antibody production market, by country, 2021-2033 (USD Million)
Table 62 Asia-Pacific antibody production market, by product, 2021-2033 (USD Million)
Table 63 Asia-Pacific antibody production market, by process, 2021-2033 (USD Million)
Table 64 Asia-Pacific antibody production market, by type, 2021-2033 (USD Million)
Table 65 Asia-Pacific antibody production market, by end use, 2021-2033 (USD Million)
Table 66 China antibody production market, by product, 2021-2033 (USD Million)
Table 67 China antibody production market, by process, 2021-2033 (USD Million)
Table 68 China antibody production market, by type, 2021-2033 (USD Million)
Table 69 China antibody production market, by end use, 2021-2033 (USD Million)
Table 70 Japan antibody production market, by product, 2021-2033 (USD Million)
Table 71 Japan antibody production market, by process, 2021-2033 (USD Million)
Table 72 Japan antibody production market, by type, 2021-2033 (USD Million)
Table 73 Japan antibody production market, by end use, 2021-2033 (USD Million)
Table 74 India antibody production market, by product, 2021-2033 (USD Million)
Table 75 India antibody production market, by process, 2021-2033 (USD Million)
Table 76 India antibody production market, by type, 2021-2033 (USD Million)
Table 77 India antibody production market, by end use, 2021-2033 (USD Million)
Table 78 South Korea antibody production market, by product, 2021-2033 (USD Million)
Table 79 South Korea antibody production market, by process, 2021-2033 (USD Million)
Table 80 South Korea antibody production market, by type, 2021-2033 (USD Million)
Table 81 South Korea antibody production market, by end use, 2021-2033 (USD Million)
Table 82 Australia antibody production market, by product, 2021-2033 (USD Million)
Table 83 Australia antibody production market, by process, 2021-2033 (USD Million)
Table 84 Australia antibody production market, by type, 2021-2033 (USD Million)
Table 85 Australia antibody production market, by end use, 2021-2033 (USD Million)
Table 86 Thailand antibody production market, by product, 2021-2033 (USD Million)
Table 87 Thailand antibody production market, by process, 2021-2033 (USD Million)
Table 88 Thailand antibody production market, by type, 2021-2033 (USD Million)
Table 89 Thailand Antibody production market, by end use, 2021-2033 (USD Million)
Table 90 Latin America antibody production market, by country, 2021-2033 (USD Million)
Table 91 Latin America antibody production market, by product, 2021-2033 (USD Million)
Table 92 Latin America antibody production market, by process, 2021-2033 (USD Million)
Table 93 Latin America antibody production market, by type, 2021-2033 (USD Million)
Table 94 Latin America antibody production market, by end use, 2021-2033 (USD Million)
Table 95 Brazil antibody production market, by product, 2021-2033 (USD Million)
Table 96 Brazil antibody production market, by process, 2021-2033 (USD Million)
Table 97 Brazil antibody production market, by type, 2021-2033 (USD Million)
Table 98 Brazil antibody production market, by end use, 2021-2033 (USD Million)
Table 99 Argentina antibody production market, by product, 2021-2033 (USD Million)
Table 100 Argentina antibody production market, by process, 2021-2033 (USD Million)
Table 101 Argentina antibody production market, by type, 2021-2033 (USD Million)
Table 102 Argentina antibody production market, by end use, 2021-2033 (USD Million)
Table 103 Middle East & Africa antibody production market, by product, 2021-2033 (USD Million)
Table 104 Middle East & Africa antibody production market, by process, 2021-2033 (USD Million)
Table 105 Middle East & Africa antibody production market, by type, 2021-2033 (USD Million)
Table 106 Middle East & Africa antibody production market, by end use, 2021-2033 (USD Million)
Table 107 South Africa antibody production market, by product, 2021-2033 (USD Million)
Table 108 South Africa antibody production market, by process, 2021-2033 (USD Million)
Table 109 South Africa antibody production market, by type, 2021-2033 (USD Million)
Table 110 South Africa antibody production market, by end use, 2021-2033 (USD Million)
Table 111 Saudi Arabia antibody production market, by product, 2021-2033 (USD Million)
Table 112 Saudi Arabia antibody production market, by process, 2021-2033 (USD Million)
Table 113 Saudi Arabia antibody production market, by type, 2021-2033 (USD Million)
Table 114 Saudi Arabia antibody production market, by end use, 2021-2033 (USD Million)
Table 115 UAE antibody production market, by product, 2021-2033 (USD Million)
Table 116 UAE antibody production market, by process, 2021-2033 (USD Million)
Table 117 UAE antibody production market, by type, 2021-2033 (USD Million)
Table 118 UAE antibody production market, by end use, 2021-2033 (USD Million)
Table 119 Kuwait antibody production market, by product, 2021-2033 (USD Million)
Table 120 Kuwait antibody production market, by process, 2021-2033 (USD Million)
Table 121 Kuwait antibody production market, by type, 2021-2033 (USD Million)
Table 122 Kuwait antibody production market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Antibody production market segmentation
Figure 6 Market snapshot, 2024
Figure 7 Market trends & outlook
Figure 8 Market driver relevance analysis (current & future impact)
Figure 9 Market restraint relevance analysis (current & future impact)
Figure 10 PESTEL analysis
Figure 11 Porter’s five forces analysis
Figure 12 Global antibody production market: Product movement analysis
Figure 13 Global antibody production market product outlook: Key takeaways
Figure 14 Global antibody production market, for instruments, 2021-2033 (USD million)
Figure 15 Global antibody production market, for bioreactors, 2021-2033 (USD million)
Figure 16 Global antibody production market, for multi-use bioreactors, 2021-2033 (USD million)
Figure 17 Global antibody production market, for single-use bioreactors, 2021-2033 (USD million)
Figure 18 Global antibody production market, for chromatography systems, 2021-2033 (USD million)
Figure 19 Global antibody production market, for filtration systems, 2021-2033 (USD million)
Figure 20 Global antibody production market, for consumables, 2021-2033 (USD million)
Figure 21 Global antibody production market, for media, 2021-2033 (USD million)
Figure 22 Global antibody production market, for buffers and reagents, 2021-2033 (USD million)
Figure 23 Global antibody production market, for chromatography resins and columns, 2021-2033 (USD million)
Figure 24 Global antibody production market, for filtration consumables and accessories, 2021-2033 (USD million)
Figure 25 Global antibody production market, for others, 2021-2033 (USD million)
Figure 26 Global antibody production market, for software, 2021-2033 (USD million)
Figure 27 Global antibody production market: Process movement analysis
Figure 28 Global antibody production market process outlook: Key takeaways
Figure 29 Global antibody production market, for upstream processing, 2021-2033 (USD million)
Figure 30 Global antibody production market, for downstream processing, 2021-2033 (USD million)
Figure 31 Global antibody production market: Type movement analysis
Figure 32 Global antibody production market type outlook: Key takeaways
Figure 33 Global antibody production market, for monoclonal antibody, 2021-2033 (USD million)
Figure 34 Global antibody production market, for polyclonal antibody, 2021-2033 (USD million)
Figure 35 Global antibody production market: End use movement analysis
Figure 36 Global antibody production end use outlook: Key takeaways
Figure 37 Global Pharmaceutical and biotechnology companies market, 2021 - 2033 (USD Million)
Figure 38 Global research laboratories market, 2021 - 2033 (USD Million)
Figure 39 Global CROs and CDMOs market, 2021 - 2033 (USD Million)
Figure 40 Regional marketplace: key takeaways
Figure 41 Regional outlook, 2021 & 2033
Figure 42 Global antibody production market: region movement analysis
Figure 43 North America antibody production market, 2021-2033 (USD million)
Figure 44 U.S. antibody production market, 2021-2033 (USD million)
Figure 45 Canada antibody production market, 2021-2033 (USD million)
Figure 46 Mexico antibody production market, 2021-2033 (USD million)
Figure 47 Europe antibody production market, 2021-2033 (USD million)
Figure 48 Germany antibody production market, 2021-2033 (USD million)
Figure 49 UK antibody production market, 2021-2033 (USD million)
Figure 50 France antibody production market, 2021-2033 (USD million)
Figure 51 Italy antibody production market, 2021-2033 (USD million)
Figure 52 Spain antibody production market, 2021-2033 (USD million)
Figure 53 Denmark antibody production market, 2021-2033 (USD million)
Figure 54 Sweden antibody production market, 2021-2033 (USD million)
Figure 55 Norway antibody production market, 2021-2033 (USD million)
Figure 56 Asia-Pacific antibody production market, 2021-2033 (USD million)
Figure 57 Japan antibody production market, 2021-2033 (USD million)
Figure 58 China antibody production market, 2021-2033 (USD million)
Figure 59 India antibody production market, 2021-2033 (USD million)
Figure 60 Australia antibody production market, 2021-2033 (USD million)
Figure 61 South Korea antibody production market, 2021-2033 (USD million)
Figure 62 Thailand antibody production market, 2021-2033 (USD million)
Figure 63 Latin America antibody production market, 2021-2033 (USD million)
Figure 64 Brazil antibody production market, 2021-2033 (USD million)
Figure 65 Argentina antibody production market, 2021-2033 (USD million)
Figure 66 Middle East and Africa antibody production market, 2021-2033 (USD million)
Figure 67 South Africa antibody production market, 2021-2033 (USD million)
Figure 68 Saudi Arabia antibody production market, 2021-2033 (USD million)
Figure 69 UAE antibody production market, 2021-2033 (USD million)
Figure 70 Kuwait antibody production market, 2021-2033 (USD million)

Companies Mentioned

The leading players profiled in this Antibody Production market report include:
  • Danaher Corporation
  • Sartorius
  • Thermo Fisher Scientific
  • Eppendorf
  • Merck KGaA
  • Lonza Group
  • AGC Biologics
  • Wuxi Biologics
  • Charles River Laboratories
  • Biointron

Table Information

Report AttributeDetails
No. of Pages180
PublishedSeptember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 17.03 Billion
Forecasted Market Value ( USD ) by 2033 $ 39.8 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2025-2033 - Product Image

Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2025-2033

  • Report
  • 147 Pages
  • Global
From
Mammalian Polyclonal IgG Antibody Market Report by Type, Product, Application, End Use, and Region 2025-2033 - Product Image

Mammalian Polyclonal IgG Antibody Market Report by Type, Product, Application, End Use, and Region 2025-2033

  • Report
  • 138 Pages
  • Global
From
Calcitonin Gene-related Peptide (CGRP) Monoclonal Antibodies Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Image

Calcitonin Gene-related Peptide (CGRP) Monoclonal Antibodies Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • 84 Pages
  • Global
From
Antibody Drug Conjugates: Market Share, and Growth Analysis by Product Type (Monoclonal Antibodies, Small Molecule Drugs), Application, End User, Technology - Product Image

Antibody Drug Conjugates: Market Share, and Growth Analysis by Product Type (Monoclonal Antibodies, Small Molecule Drugs), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Therapeutic Proteins: Market Share, and Growth Analysis by Product Type (Monoclonal Antibodies, Recombinant Proteins, Vaccines), Application, End User, Technology - Product Image

Therapeutic Proteins: Market Share, and Growth Analysis by Product Type (Monoclonal Antibodies, Recombinant Proteins, Vaccines), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.